News from the investment community on December 20, recently,Xijian TechnologyAnnounced the completion of tens of millions of yuan in Pre-A+ round of financing, this round of financing byYizhuang CapitalLead the pitchRuihua CapitalCo-investment, old shareholderYuanhui ChuangyiContinued to make additional investments, with Index Capital acting as exclusive financial advisor. The funds from this round of financing will be used for product research and development, team expansion and marketing. Only two years after its establishment, Xijian Technology has completed three rounds of financing.
Xijian Technology is based onLaboratory of Biomaterials and Mechanics of Soft Materials, Tsinghua UniversityWith more than ten years of research foundation in the field of human soft tissue mechanical characterization, he is committed to promoting the industrialization of innovative human biomechanical imaging technology and building a world-leading human soft tissue mechanical imaging platform. The company focuses on the blue ocean rigid demand market in the health field such as sports, medical beauty, and diagnosis and treatment of major diseases, and provides the industry with world-leading biomechanical imaging equipment for human soft tissues (such as skeletal muscle, ** tumors, blood vessels, nuclear cardiac organs, etc.), and jointly builds an intervention ecosystem based on human biomechanical imaging.
Up to now, the company has two global innovative products into the medical device registration process, in addition, soft material bionic body model series products have entered the commercialization stage. Among them, the world's first portable skeletal muscle structure + mechanical properties fusion imager, which can realize the quantitative detection of skeletal muscle structure and mechanical properties in vivo, and provide effective solutions to world-class problems such as strong anisotropy of tendons and muscles, active stress levels of exerted muscles, and stress measurement of stressed tendons up to megapascal level, which can give stable and reliable measurement results, and have important application scenarios in orthopedic digitalization, advanced digitalization, professional sports and other directions.
Xijian Technology is the world's first portable skeletal muscle structure + mechanical properties fusion imager.
On the medical side, the company adheres to the clinical demand as the drive, combines innovative technology and clinical benefits, and develops and promotes innovative products combining medicine, teaching and research. In the field of orthopedics and sports, Xijian Technology has been supported by the "innovation" key project of the National Orthopedics and Sports Clinical Medical Research Center, and the company will rely on the integrated innovation ecology of "medicine, research, government, enterprise and capital" of the National Clinical Center, and the collaborative innovation system covering more than 1,200 hospitals across the country to realize the company's leapfrog development from professional to industry, from innovation to popularization. In addition, the company has in-depth cooperation with top medical platforms and research institutions such as the Microsurgery Alliance, the General Hospital of the People's Liberation Army, the Third Hospital of Beijing Medical University, Beijing Friendship Hospital, Beijing Tsinghua Changgung Hospital, Beijing Sport University, etc., to jointly promote the in-depth mining and promotion of biomechanical imaging in clinical indications. At present, clinical studies on knee osteoarthritis, adolescent scoliosis, lymphedema, diabetic foot, muscle fatigue and other problems are being efficiently promoted.
At the same time, the company has actively deployed in consumer fields such as anti-aging medical aesthetics, and continues to empower scientific medical aesthetics, digital medical aesthetics and standardized training. On October 22, 2023, at the world's high-profile medical aesthetic academic event AMWC (Aesthetic & Anti-aging Medicine World Congress), Xijian Technology made its debut with ** medical beauty-related products, and the response was enthusiastic and positive.
Thanks to the deep and solid technology accumulation and efficient cross-iteration of medical engineering, Xijian Technology has been established for only two years, has completed three rounds of financing, and continues to introduce many star capitalists to accelerate its growth.
Up to now, the company has obtained the qualifications of national science and technology-based small and medium-sized enterprises, Zhongguancun high-tech enterprises, etc., has authorized more than 10 core patents, and was awarded the "2023 Ernst & Young Fudan Most Potential Enterprise" in September 2023. The company's core team comes from Tsinghua University, Peking University, Beihang University, Beijing Sport University, Huazhong University of Science and Technology, Cornell University and other top domestic and international universities. In the future, we will continue to lead the company to promote the industrialization of human biomechanical imaging platform technology, continue to empower the health and consumer industries, firmly build the world's leading human soft tissue biomechanical imaging platform, and develop an intervention ecosystem based on human biomechanical imaging with strategic partners.
Xijian Technology has won a number of qualification certifications and enterprise awards.